|
|
SPOT ON
|
|
Antidepressant drugs: opinion of the professional associations
Resistance to oseltamivir (TAMIFLU)
|
|
|
NEW ON THE MARKET
|
|
Omalizumab (XOLAIR) for allergic asthma
|
|
|
THERAPIES FROM A CRITICAL VIEW POINT
|
|
Antibiotics for atherosclerosis: no benefit - but harmful?
Critical ischemia of the lower limbs: bypass or angioplasty?
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
Misleading labelling of drugs
Biologicals for psoriasis
|
|
|
QUALITY CHECK
|
|
Capsule-preparations with 50 mg doxepine (e.g. SINQUAN)
|
|
|
IN BRIEF
|
|
Finally: no beta-carotene for smokers
Sweetener aspartame carcinogenic?
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Ketoacidosis with ziprasidone (ZELDOX)
|
|
|
SIDE EFFECTS
|
|
Macular edema with glitazones
Acid blocking agents and clostridium infections
|
|